BackIOL Chemicals and Pharmaceuticals Limited Overview
IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited Return on Equity

Valuation check: IOLCP.NS's ROE is 9.35%, below the sector sector average of 11.64%.

Get informed when a big investor buys or sells

+ Follow

ROE

9.35%

Return on Equity

9.35%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS) FAQ

The latest ROE for IOLCP.NS is 9.35%. That is below the sector sector average of 11.64%. Investors often review this figure alongside IOL Chemicals and Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, IOLCP.NS currently prints 9.35% for ROE, while the sector average sits near 11.64%. That is roughly 19.7% below the sector mean. Large gaps often invite a closer look at IOL Chemicals and Pharmaceuticals Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively IOL Chemicals and Pharmaceuticals Limited converts resources into returns. At 9.35%, IOLCP.NS may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IOLCP.NS's ROE (9.35%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.